All
8 April 2024
MaaT Pharma Presents Promising Preclinical Data at AACR for MaaT034 Aiming To Improve Patients’ Responses to Immunotherapies
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...
25 March 2024
Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline
Tubulis announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing.
25 March 2024
BlueTech Inalve announces the closing of a €4.7 million financing round
The participation of the Blue Forward FundTM, managed by Seventure Partners, and the PSIM fund, managed by Bpifrance on behalf of the French government, confirms the strong...
15 March 2024
Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development
The company, has announced the completion of a $12 million Series C financing round. The round, co-led by SymBiosis and Khosla Ventures, reflects enthusiasm for Siolta's...
1 March 2024
Clinical Microbiomics adds long-read DNA&RNA sequencing with DNASense acquisition
Danish contract research organisation Clinical Microbiomics today reveals the acquisition of DNASense, specializing in long-read DNA and RNA sequencing technologies and...
13 February 2024
Citryll announces the appointment of Maarten Kraan as Chief Medical Officer
Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat immune-mediated inflammatory diseases, today announced the appointment of Maarten...
6 February 2024
STARFISH Bioscience Raises €900,000 From Seventure Partners To Regenerate Soil Microbiomes By Developing The Next Generation Of Microbial Biostimulants For Sustainable Agriculture
Starfish Bioscience today announced that it has raised €900,000 from Seventure Partners, the world's leading investor in the microbiome field through its Health for Life...